Should you buy soaring growth stock Versarien plc after 100% rise in a week?

Rapidly-doubling growth shares like Versarien plc (LON: VRS) don’t come along very often, so is it time to buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Versarien (LSE: VRS) closed the day at 21.25p on 16 November, yet within a week they’d more than doubled to a high of 44.5p — at close on Thursday the price had dropped back to 39.1p, but that’s still an 84% gain.

So what is Versarien, and what’s going on?

The company, which describes itself as an “advanced materials engineering group,” produces something called Nanene — a particular type of ‘nano’ graphene. Graphene is claimed to be 200 times stronger than steel — and as it conducts electricity and heat, it has been touted as a replacement for copper wires and for use for circuitry on flexible surfaces.

The stuff sounds like it has great potential, and investor enthusiasm helped create a Versarien share price spike back in April — though that petered out over the subsequent few months.

Versarien is still in its cash-burn days — but the firm’s fundraising round in early November was very successful. So much so that it was more than twice oversubscribed, and was enlarged to raise a total of £2.9m.

Exciting progress

At recent rates of losses that might last around another year-and-a-half, but there’s been a big development that could potentially change all that — on 17 November, the company announced a collaboration with a “global consumer goods company,” and that’s the day the share price commenced its rapid ascent.

We’d already heard, in Versarien’s 3 November, trading update that it was “in advanced negotiations with two of the world’s largest consumer goods groups and anticipates receipt of the first purchase order imminently.” The latest update expanded that to say it “has now started collaborating with one of them to enable both groups to work together on research, development and testing of Versarien’s proprietary Nanene few layer graphene nano-platelets in polymer structures.”

As part of that, the as-yet-unidentified new partner has placed its first Nanene purchase order and will use it in polymer structures “primarily for packaging applications, for testing and evaluation, with a view to improving material strength, moisture control and recyclability.”

Negotiations are also in progress, we are told, with “a number of other multinational companies” with a view to further collaboration and commercialisation of the product.

But wait a mo…

This might make you want to rush over to your broker and place an order for Versarien shares — but before you do, you need to be aware of the risks.

Although the global graphene market is predicted to grow from a little over $20m at the end of 2016 to more than $600m by 2025 (and beyond that, who knows — very possibly into billions), the material is proving hard to commercialise and others firms have not been able to turn it into a big money-spinner yet.

And though Versarien’s new partnership deal (especially when coupled with other potential developments) does sound like a significant step forward, there are still many unanswered questions.

Will the commercialisation of the product be successful? How much of the funding for it will each partner contribute? How many ways and by what proportions will future profits be split? How long will it take before large-scale commercialisation becomes a reality? When will Versarien see its first profits? And what further funding (with accompanying dilution) will be needed before that time arrives?

Versarien could be very big, but it’s very risky.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »